SurModics Inc. +$0.72 $11.65
A Rodman & Renshaw analyst upgraded the shares to "market perform," saying the share price already reflects the risks the medical technology company is facing. (Ticker: SRDX)
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More From Star Tribune
More From Business
World
UAE bans flying of recreational drones after fatal attack
The United Arab Emirates has banned the flying of drones in the country for recreation after Yemen's Houthi rebels claimed a fatal drone attack on an oil facility and major airport in the country.
Business
Britain says Russia seeking to replace Ukraine government
The British government on Saturday accused Russia of seeking to replace Ukraine's government with a pro-Moscow administration, and said former Ukrainian lawmaker Yevheniy Murayev is being considered as a potential candidate.
Business
Mexico's energy reform strains ties with US
Mexico's plan to favor its own state-owned electrical power plants and limit energy sales by private, foreign-built projects could affect U.S. investment in Mexico, officials said during bilateral talks this week.
Coronavirus
What you need to know about COVID variants, Minnesota mask requirements and more
Advice is evolving along with the coronavirus. Here's the latest from staff and news service reports.
Local
After record year, Market Bucks program for low-income Minnesotans expands this spring
The statewide program, which offers incentives for Minnesotans on food stamps to purchase fresh, locally grown foods, landed a federal grant that will double its budget this year.
